ஆரம்ப தீர்மானம் பொறிமுறை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆரம்ப தீர்மானம் பொறிமுறை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆரம்ப தீர்மானம் பொறிமுறை Today - Breaking & Trending Today

China's Patent Office Releases Draft Measures for Patent Linkage

Tuesday, February 9, 2021
Article 76 specifies two routes for challenging a market authorization filing for a patented drug: litigation or administrative adjudication. The above-mentioned Supreme People’s Court’s litigation regulations cover the litigation route and this draft covers the administrative adjudication route. What is lacking from both though is a time limit to adjudicate these cases. The draft joint implementing measures set a 9-month deadline for challenging a marketing authorization and it is unlikely that a complex pharmaceutical litigation involving a foreign patentee could be completed within this timeframe.
An unofficial translation draft adjudication measures follows:
Article 1 In order to handle cases involving administrative rulings on patent disputes (hereinafter referred to as administrative rulings on drug patent disputes) in the process of review and approval of drug listings in accordance with the law, these Measures are form ....

Supreme People Court Patent Linkage Litigation Regulations , Property Protection Department , National Medical Products Administration , Supreme People Court , China National Intellectual Property Administration , Enforcement Guidance Office , Administrative Ruling Measures , Early Resolution Mechanism , Drug Patent Disputes , Supreme People , Court Patent Linkage Litigation Regulations , Drug Patent Dispute Early Resolution Mechanism , Patent Law , Drug Patent , National Medical Products , Patent Administrative , Intellectual Property Protection Department , Haidian District , Intellectual Property , Draft Measures For Patent Linkage , Early Resolution Mechanism For Drug Patent Disputes , உச்ச மக்கள் நீதிமன்றம் காப்புரிமை இணைப்பு வழக்கு ஒழுங்குமுறைகள் , ப்ராபர்டீ ப்ரொடெக்ஶந் துறை , உச்ச மக்கள் நீதிமன்றம் , அமலாக்கம் வழிகாட்டல் அலுவலகம் , ஆரம்ப தீர்மானம் பொறிமுறை ,

Everything you need to know about China's new Patent Law

Xiaoling Duan
On 17 October 2020 China’s top legislature, the National People’s Congress, passed the fourth round of amendments to the Patent Law, which will come into effect on 1 June 2021.
It has been eight years since the first draft was released to solicit public opinions.
This latest set of changes updates China’s patent regime in the following ways.
Civil litigation
Article 71 introduces a punitive damages regime in the context of wilful infringement, which allows a court to grant at its discretion up to five times the actual losses suffered by the patentee as a result of the infringement, the proceeds gained by the infringer from the infringement or multiples of the patent royalties, in extreme circumstances. Statutory damages have also increased to between Rmb30,000 and Rmb5 million. ....

Drug Administration Of The State Council , China National Ip Administration , National People Congress , National People , Patent Law , China National , Drug Administration , State Council , Implementation Measures , Early Resolution Mechanism , Pharmaceutical Patent Disputes , Trial Implementation , தேசிய மக்கள் காங்கிரஸ் , தேசிய மக்கள் , காப்புரிமை சட்டம் , சீனா தேசிய , நிலை சபை , செயல்படுத்தல் நடவடிக்கைகள் , ஆரம்ப தீர்மானம் பொறிமுறை , மருந்து காப்புரிமை சச்சரவுகள் , சோதனை செயல்படுத்தல் ,

Review Of The 4th Amendment Of China's Patent Law - Intellectual Property

To print this article, all you need is to be registered or login on Mondaq.com.
Twelve years from the third amendment of China s patent law,
the fourth amendment was approved by the Standing Committee of the
National People s Congress on October 17, 2020. The new
amendment will take effect on June 1, 2021. This article provides a
detailed review of the changes from the current patent law.
Enhanced Protection of Patent Rights
The first aspect of changes relates to enhanced protection of
patent rights. Specifically, it includes punitive damages,
increased statutory damage, reversed burden of proof, increased
fine for passing‐off, and extended time limit for initiating ....

National People Congress On , Standing Committee , Property Administration , Products Administration , China National , National People , Punitive Damages , Increased Statutory , Reversed Burden , Increased Fine , Extended Time , Patent Term , Intellectual Property Administration , Patent Linkage , State Council , Patent Information Registration , Napproved Drugs , Drug Products , National Medical , Early Resolution Mechanism , Drug Patent Disputes , Trial Version , Drug Experimental Data , Waxman Act , New Grace Period , Patent Right Evaluation ,

Introduction To The Fourth Amendment To The China Patent Law - Intellectual Property

To print this article, all you need is to be registered or login on Mondaq.com.
On October 17, 2020, the Standing Committee of the National
People s Congress ( SCNPC ) promulgated the Fourth
Amendment to the China Patent Law ( CPL ), which will
come into effect on June 1, 2021.
It has been 12 years since the last amendment made in 2008 when
China also formulated the Outline of the National Intellectual
Property Strategy ( Outline ). With the implementation of
the Outline, China has gradually grown into a big intellectual
property ( IP ) country characterized by the number of
valid invention patents increased from 84000 in 2007 to 1.86
million in 2019, the total number of valid registered trademarks ....

United States , China National Medical Products Administration , People Congress , Standing Committee Of The National , Supreme People Court On , China National Intellectual Property Administration , Standing Committee , China Patent Law , National Intellectual , Property Strategy , Supreme People , Issues Concerning , Infringement Disputes , China Trademark Law , China Anti Monopoly Law , China Civil Code , Implementation Measures , Early Resolution Mechanism , Drug Patent Disputes , Patent Examination , ஒன்றுபட்டது மாநிலங்களில் , மக்கள் காங்கிரஸ் , நின்று குழு ஆஃப் தி தேசிய , உச்ச மக்கள் நீதிமன்றம் ஆன் , நின்று குழு , சீனா காப்புரிமை சட்டம் ,